A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled GDC-0214, a JAK1 Inhibitor, as Single- and Multiple-Ascending Doses in Healthy Volunteers

被引：0
|
作者：
Owen, Ryan [1 ]
Galanter, Joshua [2 ]
Zhu, Rui [2 ]
Cai, Fang [2 ]
Tom, Jennifer [2 ]
Wynne, Chris [3 ]
Durk, Matthew [2 ]
Chen, Liuxi [2 ]
Kenny, Jane [2 ]
She, Gao-hong [2 ]
Vadhavkar, Shweta [2 ]
Hwang, Olivia [2 ]
Chen, Hubert [2 ]
机构：
[1] Genentech Inc, San Francisco, CA USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] Christchurch Clin Studies Trust, Christchurch, New Zealand
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2020年 / 145卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
052
引用
收藏
页码：AB17 / AB17
页数：1
相关论文
共 50 条
  • [31] Correction to: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers
    Michael E. Rothenberg
    Michael Tagen
    Jae H. Chang
    Janel Boyce-Rustay
    Michel Friesenhahn
    David H. Hackos
    Avis Hains
    Dan Sutherlin
    Michael Ward
    William Cho
    Clinical Drug Investigation, 2019, 39 : 889 - 890
  • [32] Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers
    Mariotti, Fabrizia
    Govoni, Mirco
    Lucci, Germano
    Santoro, Debora
    Nandeuil, Marie Anna
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 3399 - 3410
  • [33] Safety, tolerability and pharmacokinetics (PK) of AZD8154 (a selective PI3K?d inhibitor) after single ascending inhaled doses in healthy volunteers
    Sadiq, Muhammad Waqas
    Asimus, Sara
    Kristensson, Cecilia
    Hagberg, Anette
    Maenpaa, Jukka
    Valastro, Barbara
    Fuhr, Rainard
    Koernicke, Thomas
    Keen, Christina
    Brailsford, Wayne
    Betts, Joanne
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [34] A PHASE I STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SINGLE AND MULTIPLE DOSES OF SUBLINGUALLY ADMINISTERED ASENAPINE IN HEALTHY MALE VOLUNTEERS
    Dogterom, P.
    Timmer, C.
    de Greef, R.
    Spaans, E.
    de Vries, D.
    Peeters, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S86 - S87
  • [35] First-in-human results from a phase 1 single- and multiple-ascending dose study in healthy participants assessing the safety, pharmacokinetics, and pharmacodynamics of the interleukin-17A inhibitor JNJ-81241459
    Ling, I.
    Leung, M.
    Piantone, A.
    Sinha, V.
    Song, D.
    Scott, B.
    Pryor, M.
    Verbruggen, K.
    La, D.
    Tikhonov, I.
    Ceulemans, K.
    Nischal, S.
    Polak, M.
    Eidam, P.
    Goldberg, S.
    Rao, R.
    Yang, Y-W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S375 - S375
  • [36] Effects of Single and Multiple Ascending Doses of BI 1358894 in Healthy Male Volunteers on Safety, Tolerability and Pharmacokinetics: Two Phase I Partially Randomised Studies
    Fuertig, Rene
    Goettel, Markus
    Herich, Lena
    Hoefler, Josef
    Wiebe, Sabrina T.
    Sharma, Vikas
    CNS DRUGS, 2023, 37 (12) : 1081 - 1097
  • [37] Effects of Single and Multiple Ascending Doses of BI 1358894 in Healthy Male Volunteers on Safety, Tolerability and Pharmacokinetics: Two Phase I Partially Randomised Studies
    René Fuertig
    Markus Goettel
    Lena Herich
    Josef Hoefler
    Sabrina T. Wiebe
    Vikas Sharma
    CNS Drugs, 2023, 37 : 1081 - 1097
  • [38] Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers
    Rouphael, Nadine G.
    Hurwitz, Selwyn J.
    Hart, Mari
    Beck, Allison
    Anderson, Evan J.
    Deye, Gregory
    Osborn, Blaire
    Cai, Shu Yi
    Focht, Chris
    Amegashie, Cyrille
    Bowlin, Terry L.
    Brooks, Jennifer
    Mulligan, Mark J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (09)
  • [39] Phase 1b single and multiple ascending dose study to evaluate the safety, tolerability and pharmacokinetics of HT-100 in DMD
    Escolar, D. M.
    Davis-Golden, J.
    Loewy, J.
    Bush, E.
    Dykstra, K.
    Blaustein, M.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 802 - 803
  • [40] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ascending Multiple Oral Doses of CC 930 in Healthy Volunteers
    Kong, Linghui
    Ye, Ying
    Liu, Liangang
    Reyes, Josephine
    Wan, Yuntao
    Wu, Anfan
    Lau, Henry
    Laskin, Oscar
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1343 - 1343
12345